Related Experiment Video

Updated: Jul 5, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

siRNA-mediated Erc gene silencing suppresses tumor growth in Tsc2 mutant renal carcinoma model

Osamu Imamura1, Hiroaki Okada, Yuuki Takashima

  • 1Department of Pathology and Oncology, Juntendo University School of Medicine, Tokyo, Japan.

Cancer Letters
|May 21, 2008
PubMed

Insights

This study developed novel small interfering RNA (siRNA) microspheres for stable gene silencing. These microspheres effectively inhibited tumor growth in a hereditary renal cancer model by targeting the Erc/mesothelin gene.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Small interfering RNAs (siRNAs) are potent tools for gene silencing, with potential therapeutic applications.
  • Systemic delivery of siRNAs for stable treatment remains challenging, unlike transient delivery methods.
  • Short hairpin RNAs (shRNAs) have shown toxicity concerns due to pathway oversaturation.

Purpose of the Study:

  • To develop a stable systemic delivery method for gene silencing using siRNA microspheres.
  • To investigate the efficacy of targeting the tumor-specific Erc/mesothelin gene in a hereditary renal cancer model.

Main Methods:

  • Designed rat-specific siRNA sequences targeting Erc/mesothelin.
  • Confirmed gene silencing efficacy in vitro.
  • Utilized original siRNA microspheres for stable delivery.
  • Conducted tumor implantation experiments in a Tsc2 mutant rat model.

Main Results:

  • Validated in vitro gene silencing of Erc/mesothelin.
  • Demonstrated that siRNA microsphere delivery suppressed Erc/mesothelin expression.
  • Observed significant growth inhibition of Tsc2 mutant renal carcinoma cells in vivo.

Conclusions:

  • Original siRNA microspheres offer a viable alternative to shRNAs for stable gene silencing therapy.
  • Targeting Erc/mesothelin with siRNA microspheres shows promise for treating hereditary renal cancer.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...